NOTICE TO WARRANT HOLDERS (the “Notice”)Targanta Therapeutics Corp. • February 11th, 2009 • Pharmaceutical preparations
On January 12, 2009, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among The Medicines Company, a Delaware corporation (the “Parent”), Boxford Subsidiary Corporation, a Delaware corporation and wholly owned subsidiary of the Parent (the “Purchaser”), and the Company. Pursuant to the Merger Agreement, the Parent proposes to acquire the Company through a tender offer (the “Offer”) for all of the outstanding shares of the Company’s common stock (the “Shares”). After the closing of the Offer and upon the terms and subject to the conditions set forth in the Merger Agreement, the Purchaser will merge (the “Merger”) with and into the Company, and the Company will become a wholly owned subsidiary of the Parent.
